Onyx HealthcareROCO:6569 75 Days Payable is 46.24 as of Dec. 2025, which is 10% above its 10-year median of 41.87. GuruFocus rates ROCO:6569 with a GF Score™ of 75/100 and a GF Value™ of NT$121.39 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Onyx Healthcare ranks worse than 66.89% on this metric.
The historical rank and industry rank for Onyx Healthcare's Days Payable or its related term are showing as below:
ROCO:6569'
s Days Payable Range Over the Past 10 Years
Min: 30.53 Med: 41.87 Max: 48.13
Current: 37.51
During the past 13 years, Onyx Healthcare's highest Days Payable was 48.13. The lowest was 30.53. And the median was 41.87.
ROCO:6569's Days Payable is ranked worse than 66.89% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs ROCO:6569: 37.51
Onyx Healthcare's Days Payable
increased
from Dec. 2024 (36.95) to Dec. 2025 (46.24).
It may suggest that Onyx Healthcaredelayed paying its suppliers.
Onyx Healthcare Days Payable Related Terms
Onyx Healthcare Days Payable Historical Data
* Premium members only.
The historical data trend for Onyx Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6569 vs VEEV, BTSG, TEM: Days Payable Comparison
For the Health Information Services subindustry, Onyx Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Healthcare Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Onyx Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Onyx Healthcare's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onyx Healthcare (ROCO:6569) has a Days Payable of 46.24 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Onyx Healthcare and its competitors. This is 10% above median its historical median of 41.87. Over the past decade, Onyx Healthcare's Days Payable has ranged from 30.53 to 48.13. According to the industry distribution chart, Onyx Healthcare ranks #406 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 66.9%.
Is Onyx Healthcare's Days Payable too high?
Onyx Healthcare's current Days Payable of 46.24 is 10% above median its 10-year median of 41.87. Over the past 10 years, this metric has ranged from a low of 30.53 to a high of 48.13. The Healthcare Providers & Services industry median Days Payable is 57.13. Onyx Healthcare's value of 46.24 is 19.1% below this industry median. Based on the distribution chart, Onyx Healthcare ranks #406 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #406 out of 607 companies for Days Payable. This places Onyx Healthcare in the lower half of its industry. The industry median Days Payable is 57.13. Onyx Healthcare's value of 46.24 is 19.1% below this benchmark. Historically, Onyx Healthcare's own Days Payable has ranged from 30.53 to 48.13 over the past decade. While the company's 10-year median is 41.87 vs. the industry median of 57.13, Onyx Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Healthcare's current Days Payable of 46.24 is 19.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current Days Payable is 46.24, which is 10% above median its own 10-year median of 41.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$121.39, compared to a current price of NT$106.50 — trading 12.3% below its estimated fair value. The current Days Payable is 46.24, which is 10% above median its 10-year median of 41.87 and 19.1% below the Healthcare Providers & Services industry median of 57.13. Onyx Healthcare's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Days Payable is 46.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?
Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued.
The current stock price of NT$106.50 is trading 12.3% below its estimated GF Value™ of NT$121.39.
GuruFocus considers Onyx Healthcare to be Modestly Undervalued.
Key valuation signals for ROCO:6569:
Days Payable: 46.24 (10% above median its 10-year median of 41.87)
GF Value™: NT$121.39 vs. price of NT$106.50 (12.3% below fair value)
Industry Position: 19.1% below the Healthcare Providers & Services median (#406 of 607)
No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score
Get the complete analysis for ROCO:6569
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6569 has been successfully added to your 
